NEW YORK (GenomeWeb) – Cancer Genetics reported today after the close of the market that its fourth quarter revenues grew nearly 38 percent year over year.

For the three months ended Dec. 31, 2015, the company reported revenues of $5.5 million compared to $4.0 million in Q4 2014. The firm's biopharma services business contributed $3.0 million while its clinical services unit contributed $2.4 million of the total.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.